
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine f... Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.65 | 5.03875968992 | 12.9 | 14.05 | 12.755 | 2318935 | 13.2982096 | CS |
4 | 0.59 | 4.5524691358 | 12.96 | 14.05 | 11.81 | 1753494 | 13.04294103 | CS |
12 | 0.77 | 6.02503912363 | 12.78 | 14.05 | 11.81 | 1681692 | 12.85512929 | CS |
26 | 2.03 | 17.6215277778 | 11.52 | 14.05 | 10.12 | 1985220 | 12.10294218 | CS |
52 | 0.85 | 6.69291338583 | 12.7 | 14.05 | 9.74 | 2060197 | 11.80549351 | CS |
156 | 1.17 | 9.450726979 | 12.38 | 17.48 | 7.26 | 1931378 | 12.03584309 | CS |
260 | 9.13 | 206.561085973 | 4.42 | 21.39 | 1.8 | 2742255 | 10.48000218 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.